Demonstration of physicochemical and functional similarity between the proposed biosimilar adalimumab MSB11022 and Humira®.
about
Comparison of the pharmacokinetics, safety, and immunogenicity of MSB11022, a biosimilar of adalimumab, with Humira(®) in healthy subjects.Biosimilarity and Interchangeability: Principles and Evidence: A Systematic Review.Evaluation of analytical similarity between trastuzumab biosimilar CT-P6 and reference product using statistical analyses.
P2860
Demonstration of physicochemical and functional similarity between the proposed biosimilar adalimumab MSB11022 and Humira®.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Demonstration of physicochemic ...... alimumab MSB11022 and Humira®.
@en
type
label
Demonstration of physicochemic ...... alimumab MSB11022 and Humira®.
@en
prefLabel
Demonstration of physicochemic ...... alimumab MSB11022 and Humira®.
@en
P2093
P2860
P1476
Demonstration of physicochemic ...... alimumab MSB11022 and Humira®.
@en
P2093
Angelo Palmese
Christèle Fremaux
Fabio D'Amici
Laurent Chevalet
Laurent Magnenat
Mara Rossi
Mariagrazia Terlizzese
P2860
P304
P356
10.1080/19420862.2016.1259046
P577
2016-11-17T00:00:00Z